Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

7th Eurasian Hematology Oncology Summit
G

How I Treat Follicular Lymphoma in 2020: Rituximab vs. WW Strategy, R-CHOP vs. R-CVP, Obinutuzomab-Based Chemo

By 7th Eurasian Hematology Oncology Summit FEATURING Gianluca Gaidano
By 7th Eurasian Hematology Oncology Summit FEATURING Gianluca Gaidano
0 views
December 11, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Lymphoma
14:50
7th Eurasian Hematology Oncology Summit

How I Treat Follicular Lymphoma in 2020: Rituximab vs. WW Strategy, …

Feat. G. Gaidano
19:51
7th Eurasian Hematology Oncology Summit

How I Treat DLBCL in 2020: Can Radiotherapy Be Omitted in PET Era? I…

Feat. U. Vitolo
23:29
7th Eurasian Hematology Oncology Summit

2020 Update on IO in R/R cHL: Is Long-Term Therapy w/ Nivo Feasible …

Feat. T. Tuglular
15:27
7th Eurasian Hematology Oncology Summit

How I Treat HL in 2020: What Is the Role of PET-Adapted Strategies? …

Feat. C. Gisselbrecht
21:20
7th Eurasian Hematology Oncology Summit

How I Treat Mantle Cell Lymphoma in 2020: Induction Options, ASCT, a…

Feat. C. Schiffer